Estrogen - a potential treatment for schizophrenia.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Schizophrenia Research

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/s0920-9964(00)90362-1PMID 11278160
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Neuroendocrine response to antipsychotics: effects of drug type and gender.

  1999cited by this paper
• Testosterone as well as estrogen increases serotonin2A receptor mRNA and binding site densities in the male rat brain.

  1998cited by this paper
• The role of estrogen in schizophrenia.

  1996cited by this paper
• A clinical trial of the effects of estrogen in acutely psychotic women.

  1996cited by this paper
• Further evidence for a specific role of estradiol in schizophrenia?

  1994cited by this paper
• Modulation of Brain Dopamine Transmission by Sex Steroids

  1994cited by this paper
• Sex differences and effects of estrogen on dopamine and DOPAC release from the striatum of male and female CD-1 mice.

  1994cited by this paper
• Generating and testing a causal explanation of the gender difference in age at first onset of schizophrenia

  1993cited by this paper
• Gender differences in pharmacokinetics and pharmacodynamics of psychotropic medication.

  1992cited by this paper
• An animal model for the effects of estradiol on dopamine-mediated behavior: implications for sex differences in schizophrenia.

  1991cited by this paper
• The role of estrogens in schizophrenia gender differences.

  1990cited by this paper
• Gender and schizophrenia.

  1990cited by this paper
• Gender differences in the course of schizophrenia.

  1988cited by this paper
• The positive and negative syndrome scale (PANSS) for schizophrenia.

  1987cited by this paper
• Current outcome in schizophrenia: women vs men

  1986cited by this paper
• Similar effect of estradiol and haloperidol on experimental tardive dyskinesia in monkeys.

  1984cited by this paper
• Effect of prolactin and estradiol on rat striatal dopamine receptors.

  1982cited by this paper
• Effects of chronic estrogen treatment on dopamine concentrations and turnover in discrete brain nuclei of ovariectomized rats.

  1981cited by this paper
• Effect of chronic estradiol and haloperidol treatment on striatal dopamine receptors.

  1981cited by this paper
• Influence of female sex hormones on neuroleptic-induced behavioral supersensitivity.

  1980cited by this paper
• Modulation of dopamine receptor sensitivity by estrogen.

  1980cited by this paper
• Effects of Catechol Estrogens1 and Catecholamines on Hypothalamic and Corpus Striatal Tyrosine Hydroxylase Activity

  1980cited by this paper
• Periodic psychosis recurring in association with menstrual cycle.

  1978cited by this paper

• Efficacy and safety of anti-inflammatory drug-assisted treatment of symptoms in patients with schizophrenia: a meta-analysis

  2026cites this paper
• Single-Cell Transcriptional Profiling Reveals Cell Type-Specific Sex-Dependent Molecular Patterns of Schizophrenia

  2025cites this paper
• Sex/gender differences in hemispheric asymmetries.

  2025cites this paper
• Risk of Schizophrenia After a Diagnosis of Epilepsy: A Nationwide Matched Cohort Study in South Korea.

  2025cites this paper
• Cognitive, neuroimaging, and genetic insights on the interthalamic adhesion from a large cohort study of 591 subjects

  2025cites this paper
• Estrogen and psychosis — a review and future directions

  2024cites this paper
• Increased regional activity of a pro-autophagy pathway in schizophrenia as a contributor to sex differences in the disease pathology

  2024cites this paper
• Estrogen - A key neurosteroid in the understanding and treatment of mental illness in women.

  2023cites this paper
• Immunomodulatory Effects of Clozapine: More Than Just a Side Effect in Schizophrenia

  2023cites this paper
• Evidence-Based Recommendations for the Pharmacological Treatment of Women with Schizophrenia Spectrum Disorders

  2023cites this paper
• Adjunctive agents to antipsychotics in schizophrenia: a systematic umbrella review and recommendations for amino acids, hormonal therapies and anti-inflammatory drugs

  2023cites this paper
• Estradiol driven change in hallucination proneness across the menstrual cycle as studied with a white noise paradigm.

  2023cites this paper
• Augmentation Therapies as Treatments for Coexisting Somatic Problems in Schizophrenia—A Systematic Review

  2023cites this paper
• Sex and the Estrous-Cycle Phase Influence the Expression of G Protein-Coupled Estrogen Receptor 1 (GPER) in Schizophrenia: Translational Evidence for a New Target

  2023cites this paper
• Risk for midlife psychosis in women: critical gaps and opportunities in exploring perimenopause and ovarian hormones as mechanisms of risk

  2022cites this paper
• Estradiol and raloxifene as adjunctive treatment for women with schizophrenia: A meta‐analysis of randomized, double‐blind, placebo‐controlled trials

  2022cites this paper
• Adolescent raloxifene treatment in females prevents cognitive deficits in a neurodevelopmental rodent model of schizophrenia.

  2022cites this paper
• Menopause in women with schizophrenia, schizoaffective disorder and bipolar disorder.

  2021cites this paper
• Suicidality and Illness Course Worsening in a Male Patient with Bipolar Disorder during Tamoxifen Treatment for ER+/HER2+ Breast Cancer

  2021cites this paper
• Prescribing Tamoxifen in Patients With Mood Disorders

  2021cites this paper
• Efficacy and safety of anti-inflammatory agents in treatment of psychotic disorders - a comprehensive systematic review and meta-analysis.

  2020cites this paper
• Antipsychotic effects of sex hormones and atypical hemispheric asymmetries.

  2020cites this paper
• Diagnostic stability and long-term symptomatic and functional outcomes in first-episode antipsychotic-naïve patients with schizophrenia

  2019cites this paper
• An update on the efficacy of anti-inflammatory agents for patients with schizophrenia: a meta-analysis

  2019cites this paper
• Estrogens and SERMS as adjunctive treatments for schizophrenia.

  2019cites this paper
• Hypothalamic-pituitary-gonadal axis dysfunction: An innate pathophysiology of schizophrenia?

  2019cites this paper
• Adjunctive use of anti-inflammatory drugs for schizophrenia: A meta-analytic investigation of randomized controlled trials

  2019cites this paper
• The past and future of novel, non-dopamine-2 receptor therapeutics for schizophrenia: A critical and comprehensive review.

  2019cites this paper
• Considering the role of adolescent sex steroids in schizophrenia

  2018cites this paper
• Pharmacotherapy for schizophrenia in postmenopausal women

  2018cites this paper
• Upregulation of vitamin D-related genes in schizophrenic patients

  2018cites this paper
• Sex: A Significant Risk Factor for Neurodevelopmental and Neurodegenerative Disorders

  2018cites this paper
• Schizophrenia in mid-adulthood after prenatal exposure to the Chinese Famine of 1959-1961.

  2017cites this paper
• Neural - hormonal responses to negative affective stimuli: Impact of dysphoric mood and sex.

  2017cites this paper
• Two‐hit model of schizophrenia induced by neonatal immune activation and peripubertal stress in rats: Study of sex differences and brain oxidative alterations

  2017cites this paper
• Oestrogens, prolactin, hypothalamic-pituitary-gonadal axis, and schizophrenic psychoses.

  2017cites this paper
• GPER1 mediates estrogen-induced neuroprotection against oxygen-glucose deprivation in the primary hippocampal neurons.

  2016cites this paper
• Phytochemicals: Potential in Management of Climacteric Neurobiology.

  2016cites this paper
• High estrogen and chronic haloperidol lead to greater amphetamine-induced BOLD activation in awake, amphetamine-sensitized female rats.

  2016cites this paper
• Kynurenines, Gender and Neuroinflammation; Showcase Schizophrenia

  2016cites this paper
• Biological factors underlying sex differences in neurological disorders.

  2015cites this paper
• Integration of neural networks activated by amphetamine in females with different estrogen levels: a functional imaging study in awake rats.

  2015cites this paper
• Postnatal MK-801 treatment of female rats impairs acquisition of working memory, but not reference memory in an eight-arm radial maze; no beneficial effects of enriched environment

  2015cites this paper
• High estradiol levels improve false memory rates and meta-memory in highly schizotypal women.

  2015cites this paper
• Sex differences, hormones, and fMRI stress response circuitry deficits in psychoses.

  2015cites this paper
• A Role for Estrogen in Schizophrenia: Clinical and Preclinical Findings

  2015cites this paper
• Drug repurposing and emerging adjunctive treatments for schizophrenia

  2015cites this paper
• Raloxifene trial in postmenopausal woman with treatment-resistant schizophrenia

  2015cites this paper
• Changes in brain volume in response to estradiol levels, amphetamine sensitization and haloperidol treatment in awake female rats.

  2015cites this paper
• Evidence of a sex-dependent restrictive epigenome in schizophrenia.

  2015cites this paper
• Sex hormones and oxytocin augmentation strategies in schizophrenia: A quantitative review.

  2015cites this paper
• Estradiol for treatment-resistant schizophrenia: a large-scale randomized-controlled trial in women of child-bearing age

  2014cites this paper
• Neuroimmunological Aberrations and Cerebral Asymmetry Abnormalities in Schizophrenia: Select Perspectives on Pathogenesis

  2014cites this paper
• Demographic features and premorbid personality disorder traits in relation to age of onset and sex in paranoid schizophrenia.

  2014cites this paper
• Estrogen potentiates the behavioral and nucleus accumbens dopamine response to continuous haloperidol treatment in female rats

  2014cites this paper
• Efficacy of anti-inflammatory agents to improve symptoms in patients with schizophrenia: an update.

  2014cites this paper
• A four week randomised control trial of adjunctive medroxyprogesterone and tamoxifen in women with mania.

  2014cites this paper
• Overcoming Drug Development Bottlenecks With Repurposing: Old drugs learn new tricks

  2014cites this paper
• Nocturnal Anxiety in a Youth with Rapid-onset Obesity, Hypothalamic Dysfunction, Hypoventilation, and Autonomic Dysregulation (ROHHAD).

  2013cites this paper
• The Role of Estrogen in the Treatment of Men with Schizophrenia

  2013cites this paper
• Antidopaminergic effects of leucine and genistein on shizophrenic rat models.

  2013cites this paper
• Psychiatrists’ and Psychologists’ Practice Patterns: Different Profiles in a Spanish Clinical Sample

  2013cites this paper
• Differential effects of estrogen and testosterone on auditory sensory gating in rats

  2013cites this paper
• Repurposed drugs for the treatment of schizophrenia and bipolar disorders.

  2013cites this paper
• Association of estrogen receptor alpha gene polymorphism with age at onset, general psychopathology symptoms, and therapeutic effect of schizophrenia

  2013cites this paper
• Sex steroids and schizophrenia

  2012cites this paper
• Successful use of adjuvant raloxifene treatment in clozapine-resistant schizophrenia

  2012cites this paper
• Abnormally rapid reversal learning and reduced response to antipsychotic drugs following ovariectomy in female rats.

  2012cites this paper
• Neuroanatomical substrates of the disruptive effect of olanzapine on rat maternal behavior as revealed by c-Fos immunoreactivity.

  2012cites this paper
• Estradiol attenuates the cognitive deficits in the novel object recognition task induced by sub-chronic phencyclidine in ovariectomized rats.

  2012cites this paper
• Management of the Negative Symptoms of Schizophrenia

  2012cites this paper
• Role of Estrogen Treatment in the Management of Schizophrenia

  2012cites this paper
• Pharmacological treatment of schizophrenia: a critical review of the pharmacology and clinical effects of current and future therapeutic agents

  2012cites this paper
• Selective estrogen receptor modulator promotes weight loss in ovariectomized female rhesus monkeys (Macaca mulatta) by decreasing food intake and increasing activity.

  2012cites this paper
• Estrogen augmentation in schizophrenia: a quantitative review of current evidence.

  2012cites this paper
• Special biological issues in the management of women with schizophrenia

  2012cites this paper
• Sexual dimorphism in schizophrenia: is there a need for gender-based protocols?

  2011cites this paper
• Estrogens and gonadal function in schizophrenia and related psychoses.

  2011cites this paper
• Estrogens and men with schizophrenia: is there a case for adjunctive therapy?

  2011cites this paper
• Antipsychotic-Induced Hyperprolactinaemia

  2011cites this paper
• Transgender Late Onset Psychosis: The Role of Sex Hormones

  2011cites this paper
• Interaction of estrogen with central serotonergic mechanisms in human sensory processing: loudness dependence of the auditory evoked potential and mismatch negativity

  2011cites this paper
• Full length TrkB potentiates estrogen receptor alpha mediated transcription suggesting convergence of susceptibility pathways in schizophrenia.

  2011cites this paper
• Schizophrenia and Stein–Leventhal syndrome: comorbidity features

  2011cites this paper
• The role of estrogen and testosterone in female rats in behavioral models of relevance to schizophrenia

  2011cites this paper
• Raloxifene as an adjunctive treatment for postmenopausal women with schizophrenia: a double-blind, randomized, placebo-controlled trial.

  2011cites this paper
• The effect of gonadectomy on prepulse inhibition and fear-potentiated startle in adolescent rhesus macaques.

  2010cites this paper
• Steroids‐Dopamine Interactions in the Pathophysiology and Treatment of CNS Disorders

  2010cites this paper
• Iptakalim: a potential antipsychotic drug with novel mechanisms?

  2010cites this paper
• Dysregulation of kisspeptin and neurogenesis at adolescence link inborn immune deficits to the late onset of abnormal sensorimotor gating in congenital psychological disorders

  2010cites this paper
• Sex-Dependent Antipsychotic Capacity of 17β-Estradiol in the Latent Inhibition Model: A Typical Antipsychotic Drug in Both Sexes, Atypical Antipsychotic Drug in Males

  2010cites this paper
• Estrogen Treatment Blocks 8-Hydroxy-2-dipropylaminotetralin- and Apomorphine-Induced Disruptions of Prepulse Inhibition: Involvement of Dopamine D1 or D2 or Serotonin 5-HT1A, 5-HT2A, or 5-HT7 Receptors

  2010cites this paper
• The effect of estrogen on dopamine and serotonin receptor and transporter levels in the brain: an autoradiography study.

  2010cites this paper
• Treating schizophrenia: novel targets for the cholinergic system.

  2010cites this paper
• Research in people with psychosis risk syndrome: a review of the current evidence and future directions.

  2010cites this paper
• Contrasting Effects of Increased and Decreased Dopamine Transmission on Latent Inhibition in Ovariectomized Rats and Their Modulation by 17β-Estradiol: An Animal Model of Menopausal Psychosis?

  2010cites this paper
• Successful use of adjuvant phytoestrogens in schizoaffective disorder: a case report.

  2009cites this paper
• Is oestrogen neuroprotective?

  2009cites this paper
• Transcriptional Interaction of an Estrogen Receptor Splice Variant and ErbB4 Suggests Convergence in Gene Susceptibility Pathways in Schizophrenia*

  2009cites this paper
• Estrogen and brain vulnerability

  2009cites this paper